baclofen has been researched along with Basal Ganglia Diseases in 5 studies
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Baclofen and oxazepam were prescribed secondary to right-sided hemiparesis contractures." | 1.34 | Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities. ( Brahm, NC; Brown, RC; McElwain, DL, 2007) |
| "When selegiline was stopped after 9 years of treatment, abnormal involuntary movements improved to pretreatment level and psychiatric behaviour returned to normal." | 1.32 | Adverse effects of dopamine potentiation by long-term treatment with selegiline. ( Hollán, S; Magyar, K; Vécsei, L, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Virmani, T | 1 |
| Greene, PE | 1 |
| Pearson, TS | 1 |
| Hollán, S | 1 |
| Vécsei, L | 1 |
| Magyar, K | 1 |
| Brahm, NC | 1 |
| McElwain, DL | 1 |
| Brown, RC | 1 |
| Liebman, J | 1 |
| Neale, R | 1 |
| De Andrade, LA | 1 |
| Bertolucci, PH | 1 |
5 other studies available for baclofen and Basal Ganglia Diseases
| Article | Year |
|---|---|
Delayed onset of progressive chorea after acute basal ganglia injury.
Topics: Adult; Baclofen; Basal Ganglia Diseases; Chorea; Clonazepam; GABA Modulators; Humans; Male; Muscle R | 2013 |
Adverse effects of dopamine potentiation by long-term treatment with selegiline.
Topics: Adolescent; Adult; Anemia, Hemolytic, Congenital; Antiparkinson Agents; Baclofen; Basal Ganglia; Bas | 2004 |
Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities.
Topics: Adult; Algorithms; Antipsychotic Agents; Aripiprazole; Baclofen; Basal Ganglia Diseases; Citalopram; | 2007 |
Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Baclofen; Basal Ganglia Diseases; Clozapine; Diaz | 1980 |
[Treatment of Meige disease with a GABA receptor agonist].
Topics: Baclofen; Basal Ganglia Diseases; Drug Evaluation; Female; Humans; Male; Meige Syndrome; Middle Aged | 1985 |